BPC
NEO icon

Bryce Point Capital’s NeoGenomics NEO Stock Holding History

Bryce Point Capital’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$495K Buy
+64,084
New +$449K 0.6% 103

Other funds holding NEO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bryce Point Capital's NEO Position: Q3 2025 in Review

Bryce Point Capital opened a new position in NeoGenomics (NEO) in Q3 2025: 64,084 shares worth $495K. The stake represents 0.6% of the portfolio and ranks #103 among its holdings.

254 funds tracked by Wall St. Rank hold NEO as of Q3 2025.

  • Bryce Point Capital held 64,084 shares of NeoGenomics worth $495K as of Q3 2025.
  • NeoGenomics was a new Bryce Point Capital position in Q3 2025.
  • NeoGenomics made up 0.6% of Bryce Point Capital's portfolio in Q3 2025, its #103 holding.
  • 254 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2025.

Based on Bryce Point Capital's 13F filing for Q3 2025, filed 6 Nov 2025.